You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

17p deletion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

Terminated
Has Results
  • CLL
  • SLL
  • Boston, Massachusetts
  • +1 more
Jan 30, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Leukemia, Leukemia, Lymphocytyc, CLL (Chronic Lymphocytic Leukemia) Trial run by the NHLBI (PCI 32765)

Active, not recruiting
Has Results
  • Leukemia
  • +3 more
  • PCI 32765
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 2, 2021

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • Tempe, Arizona
    • +14 more
    Jan 12, 2022

    Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

    Completed
    • Leukemia, Lymphocytic, Chronic
    • Dresden, Germany
    • +10 more
    Jan 13, 2023

    Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Deletion 17P Syndrome
    • Ancona, Italy
    • +14 more
    Mar 24, 2022

    Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • +2 more
    • ABT-199 (Main Cohort)
    • ABT-199 (Safety Expansion Cohort)
    • Tucson, Arizona
    • +47 more
    Nov 19, 2021

    Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Bad Saarow, Germany
    • +29 more
    May 4, 2022

    Angelman Syndrome Trial (60 mg QD Alogabat, 40 mg QD Alogabat, 7 mg QD Alogabat)

    Not yet recruiting
    • Angelman Syndrome
    • 60 mg QD Alogabat
    • +4 more
    • (no location specified)
    Feb 1, 2023

    Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Louisville, Kentucky
    • +66 more
    Nov 9, 2022

    16P11.2 Deletion Syndrome Trial in Boston, Houston, Seattle (Arbaclofen, Placebo oral tablet)

    Suspended
    • 16P11.2 Deletion Syndrome
    • Boston, Massachusetts
    • +2 more
    Jul 28, 2021

    Chromosome 9 P Minus Syndrome

    Recruiting
    • Chromosome 9P Deletion Syndrome
    • +4 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 30, 2021

      Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • 1.1 GBq (30 mCi) of 177Lu-P17-087
      • 1.1 GBq (30 mCi) of 177Lu-P17-088
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Oct 30, 2022

      22q11.2 Deletion Syndrome Trial in Philadelphia (NFC-1)

      Completed
      • 22q11.2 Deletion Syndrome
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Mar 24, 2022

      22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21 Trial in Worldwide

      Completed
      • 22q11 Deletion Syndrome
      • +10 more
        • San Francisco, California
        • +20 more
        Jan 27, 2021

        Moderate to Severe Chronic Plaque Psoriasis Trial (CT-P17, EU-approved Humira)

        Not yet recruiting
        • Moderate to Severe Chronic Plaque Psoriasis
        • CT-P17
        • EU-approved Humira
        • (no location specified)
        Aug 8, 2022

        GROWing Up With Rare GENEtic Syndromes

        Recruiting
        • Prader-Willi Syndrome
        • +32 more
        • Retrospective file studies
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus Medical Center
        Jul 3, 2020

        Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))

        Not yet recruiting
        • Group A Streptococcal Infection
        • p*17-K4S2 (25 µg/mL)
        • +4 more
        • Edmonton, Alberta, Canada
          University of Alberta Hospital
        Jul 26, 2022

        Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

        Completed
        • Chronic Lymphocytic Leukemia
          • Calgary, Alberta, Canada
          • +12 more
          Jul 7, 2022

          Chronic Lymphocytic Leukemia Trial (Zebutinib&BR or Zebutinib&FCR)

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • Zebutinib&BR or Zebutinib&FCR
          • (no location specified)
          Jul 27, 2021

          Emotion Regulation, Depression, Anxiety Trial in Thunder Bay (Usual Practice + JoyPop)

          Recruiting
          • Emotion Regulation
          • +3 more
          • Usual Practice + JoyPop
          • Thunder Bay, Ontario, Canada
            Lakehead University
          Jun 9, 2023

          HIV Trial in Rochester (HIV p17/p24:Ty-VLP, Aluminum hydroxide)

          Completed
          • HIV Infections
          • HIV p17/p24:Ty-VLP
          • Aluminum hydroxide
          • Rochester, New York
            Univ. of Rochester AVEG
          Oct 28, 2021

          CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

          Not yet recruiting
          • CLL/SLL
          • Orelabrutinib and BG
          • Wuhan, Hubei, China
          • +1 more
          Jun 15, 2023

          Chronic Lymphocytic Leukemia Trial in San Diego (ISF35)

          Completed
          • Chronic Lymphocytic Leukemia
          • ISF35
          • San Diego, California
            University of California, San Diego Moores Cancer Center
          Sep 15, 2021